Twitxy Saved

Kelly Fitzgerald

@KellyNFitz

GU oncology at UCSF | MSKCC fellowship alum | cancer immunology and metabolism | tweets are mine
San Francisco, CA Joined April 2009
130 Following 269 Followers 68 Posts

Latest posts 5

Kelly Fitzgerald @KellyNFitz
Interesting to consider a ‘very favorable risk’ subgroup of ccRCC patients and the role of VEGFR targeted therapies here. How will HIF2a blockade perform in these patients?
#MartinZarba @DrDanielHeng @UCalgaryMed with IMDC very/favorable risk #kidneycancer — all regimens w excellent survival. Ipi-nivo doublet falls short in very favorable risk RCC. @ASCO #ASCO24 @OncoAlert
View quoted post on X